SMTL ID : 7d0d.1

S protein of SARS-CoV-2 in complex bound with P5A-3C12_2B

Coordinates

PDB Format Compare

Method

ELECTRON MICROSCOPY

Oligo State

hetero-3-2-2-mer

Ligands

22 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 2 residues within 4Å: Chain A: N.331, Q.580 No protein-ligand interaction detected (PLIP) NAG-NAG.2: 2 residues within 4Å: Chain A: F.342, N.343 No protein-ligand interaction detected (PLIP) NAG-NAG.3: 2 residues within 4Å: Chain A: N.709 Chain G: D.796 No protein-ligand interaction detected (PLIP) NAG-NAG.4: 5 residues within 4Å: Chain A: N.717, L.922, N.925, Q.926, Q.1071 2 PLIP interactions: 2 interactions with chain A Hydrophobic interactions: A:L.922, A:N.925 NAG-NAG.5: 2 residues within 4Å: Chain A: N.801, S.803 No protein-ligand interaction detected (PLIP) NAG-NAG.6: 3 residues within 4Å: Chain A: A.706, E.1072, N.1074 No protein-ligand interaction detected (PLIP) NAG-NAG.7: 4 residues within 4Å: Chain A: N.1098, T.1100, H.1101, F.1103 No protein-ligand interaction detected (PLIP) NAG-NAG.8: 1 residues within 4Å: Chain A: N.1134 No protein-ligand interaction detected (PLIP) NAG-NAG.9: 4 residues within 4Å: Chain B: N.331, P.579, Q.580, L.582 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:L.582 NAG-NAG.10: 3 residues within 4Å: Chain A: D.796 Chain B: N.709, G.1131 No protein-ligand interaction detected (PLIP) NAG-NAG.11: 3 residues within 4Å: Chain B: N.717, L.922, Q.926 1 PLIP interactions: 1 interactions with chain B Hydrophobic interactions: B:L.922 NAG-NAG.12: 3 residues within 4Å: Chain B: N.801, S.803, Q.804 No protein-ligand interaction detected (PLIP) NAG-NAG.13: 4 residues within 4Å: Chain B: N.1098, T.1100, H.1101, F.1103 No protein-ligand interaction detected (PLIP) NAG-NAG.14: 1 residues within 4Å: Chain B: N.1134 No protein-ligand interaction detected (PLIP) NAG-NAG.15: 1 residues within 4Å: Chain G: N.331 No protein-ligand interaction detected (PLIP) NAG-NAG.16: 2 residues within 4Å: Chain G: F.342, N.343 No protein-ligand interaction detected (PLIP) NAG-NAG.17: 4 residues within 4Å: Chain G: N.717, L.922, Q.926, Q.1071 1 PLIP interactions: 1 interactions with chain G Hydrophobic interactions: G:L.922 NAG-NAG.18: 3 residues within 4Å: Chain G: N.801, S.803, Q.804 No protein-ligand interaction detected (PLIP) NAG-NAG.19: 3 residues within 4Å: Chain G: A.706, E.1072, N.1074 No protein-ligand interaction detected (PLIP) NAG-NAG.20: 3 residues within 4Å: Chain G: N.1098, T.1100, F.1103 No protein-ligand interaction detected (PLIP) NAG-NAG.21: 1 residues within 4Å: Chain G: N.1134 No protein-ligand interaction detected (PLIP) NAG-NAG.22: 4 residues within 4Å: Chain B: A.706, E.1072, K.1073, N.1074 No protein-ligand interaction detected (PLIP)

26 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.23: 2 residues within 4Å: Chain A: Y.28, N.61 Ligand excluded by PLIP NAG.24: 4 residues within 4Å: Chain A: N.122, N.125, V.127, F.157 Ligand excluded by PLIP NAG.25: 1 residues within 4Å: Chain A: N.165 Ligand excluded by PLIP NAG.26: 1 residues within 4Å: Chain A: N.234 Ligand excluded by PLIP NAG.27: 2 residues within 4Å: Chain A: E.281, N.282 Ligand excluded by PLIP NAG.28: 1 residues within 4Å: Chain A: N.603 Ligand excluded by PLIP NAG.29: 1 residues within 4Å: Chain A: N.616 Ligand excluded by PLIP NAG.30: 2 residues within 4Å: Chain A: H.655, N.657 Ligand excluded by PLIP NAG.31: 2 residues within 4Å: Chain B: Y.28, N.61 Ligand excluded by PLIP NAG.32: 4 residues within 4Å: Chain B: N.122, T.124, V.127, K.129 Ligand excluded by PLIP NAG.33: 2 residues within 4Å: Chain B: N.164, N.165 Ligand excluded by PLIP NAG.34: 1 residues within 4Å: Chain B: N.234 Ligand excluded by PLIP NAG.35: 3 residues within 4Å: Chain B: N.280, E.281, N.282 Ligand excluded by PLIP NAG.36: 3 residues within 4Å: Chain B: F.338, G.339, N.343 Ligand excluded by PLIP NAG.37: 1 residues within 4Å: Chain B: N.603 Ligand excluded by PLIP NAG.38: 1 residues within 4Å: Chain B: N.616 Ligand excluded by PLIP NAG.39: 1 residues within 4Å: Chain B: N.657 Ligand excluded by PLIP NAG.40: 2 residues within 4Å: Chain G: Y.28, N.61 Ligand excluded by PLIP NAG.41: 3 residues within 4Å: Chain G: N.122, T.124, V.127 Ligand excluded by PLIP NAG.42: 2 residues within 4Å: Chain G: E.132, N.165 Ligand excluded by PLIP NAG.43: 2 residues within 4Å: Chain G: G.232, N.234 Ligand excluded by PLIP NAG.44: 3 residues within 4Å: Chain G: N.280, E.281, N.282 Ligand excluded by PLIP NAG.45: 2 residues within 4Å: Chain G: N.603, T.604 Ligand excluded by PLIP NAG.46: 1 residues within 4Å: Chain G: N.616 Ligand excluded by PLIP NAG.47: 1 residues within 4Å: Chain G: N.657 Ligand excluded by PLIP NAG.48: 4 residues within 4Å: Chain B: D.796 Chain G: N.709, I.1130, G.1131 Ligand excluded by PLIP

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Yan, R. et al., Structural basis for bivalent binding and inhibition of SARS-CoV-2 infection by human potent neutralizing antibodies. Cell Res. (2021)

Release Date

2021-03-10

Peptides

Spike glycoprotein: ABG
Heavy chain of P5A-3C12: CE
Light chain of P5A-3C12: DF

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
C

G
B

C
H

E
G

D
L

F
F

Spike glycoprotein

Heavy chain of P5A-3C12

Light chain of P5A-3C12

Related Entries With Identical Sequence